EHRA Premium Access

Pulsed field ablation as the first choice regarding oesophageal safety for atrial fibrillation ablation?

Topic: Rhythm Control, Catheter Ablation


About the speaker

Doctor Josip Katic

University Hospital Center Split, Split (Croatia)
0 follower

6 more presentations in this session

Persistent phrenic nerve palsy after atrial fibrillation ablation: follow-up data from the Netherlands Heart Registration

Speaker: Doctor J. de Jong (Amsterdam, NL)


Impact of high-power and very high-power short-duration radiofrequency ablation on procedure characteristics and first-pass isolation during pulmonary vein isolation

Speaker: Doctor Z. Sallo (Budapest, HU)


Areas of minimal generator impedance drop during the index atrial fibrillation ablation correlate with pulmonary vein reconnection sites despite adopting the CLOSE protocol

Speaker: Doctor A. Malaweera (London, GB)


Comparison of left atrial lesion size and troponin release of two novel single shot devices for pulmonary vein isolation: pulsed field ablation vs. multi-electrode radiofrequency balloon

Speaker: Doctor M. Lemoine (Hamburg, DE)


The triangle correlation among the impact on serum S100B protein release, incidence of the silent cerebral ischemic phenomena and pulsed field ablation for patients with atrial fibrillation.

Speaker: Professor K. Chun (Frankfurt am Main, DE)


Access the full session

Moderated ePosters - News on AF ablation

Speakers: Doctor J. Katic, Doctor J. de Jong, Doctor Z. Sallo, Doctor A. Malaweera, Doctor M. Lemoine...

About the event


EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Related content

EHRA Premium Access

Detection of endo-epicardial atrial low-voltage areas using unipolar and omnipolar voltage mapping

3 April 2022

EHRA Premium Access

Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures

3 April 2022

EHRA Premium Access

Selective epicardial pulsed field ablation of atrial ganglionated plexi causes anti-arrhythmic prolongation of refractoriness: demonstration of feasibility in cardiac surgery patients

3 April 2022

This platform is supported by

logo Novo Nordisk